-
Product Insights
Arrhythmias – Drugs In Development, 2023
Global Markets Direct’s, ‘Arrhythmias - Drugs In Development, 2023’, provides an overview of the Arrhythmias pipeline landscape. The report provides comprehensive information on the therapeutics under development for Arrhythmias, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key...
-
Product Insights
Quarterly Liqueurs pricing trends in Germany
Consumers' preferences for stores are most heavily influenced by pricing and promotions, but brands and retailers continue to adjust prices and promotions based on insufficient information from expensive, drawn-out, and incomplete audits of rival techniques. Brands and retailers can benefit from the unique intelligence provided by GlobalData Ecommerce Price Tracker, covering millions of SKUs, to identify, anticipate, and implement important business choices. GlobalData's new report titled "Quarterly Liqueurs pricing trends in Germany" serves as a crucial resource for analyzing pricing...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – budiodarone
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry budiodarone Drug Details Budiodarone (ATI-2042) is under development for the treatment of in patients...
-
Product Insights
Angina (Angina Pectoris) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Angina (Angina Pectoris) is a term that describes chest pain caused by myocardial ischemia. Angina generally is a symptom of coronary artery disease. Some of the most common symptoms of Angina include anxiety, increased or irregular heart rate, paleness, cold sweat, and a feeling of doom. Risk factors include smoking, a sedentary lifestyle, high blood fat or cholesterol, and hypercholesterolemia. The Angina pipeline drugs market research report provides comprehensive information on the Angina Pectoris targeted therapeutics, complete with analysis by...
-
Product Insights
Arrhythmias Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Arrhythmias pipeline market research report provides comprehensive information on the therapeutics under development for arrhythmias, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Arrhythmias and features dormant and discontinued projects.
-
Product Insights
Thromboembolism Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
When a blood clot (thrombus) breaks and travels in the blood, it is known as a thromboembolism. Symptoms include warmth, edema, and erythema, and may also include dilated veins (collaterals) on the chest wall or leg. Risk factors include hypertension, diabetes mellitus, cigarette smoking, and high cholesterol levels. Treatment includes anticoagulants, thrombolytic therapy, and surgery. The Thromboembolism drugs in development market research report provides comprehensive information on the therapeutics under development for Thromboembolism, complete with analysis by stage of development,...
-
Product Insights
Atrial Fibrillation Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Atrial fibrillation pipeline market research report provides comprehensive information on the therapeutics under development for Atrial Fibrillation, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Atrial Fibrillation and features dormant and...